Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17995 publications
Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement.
Journal: Journal of medicinal chemistry
Published: October 15, 2025
Tophaceous gout with milk of urate mimicking infection.
Journal: BMJ case reports
Published: October 14, 2025
Higher cardiometabolic index elevates the risk of hyperuricemia in the elderly: findings from the China health and retirement longitudinal study.
Journal: Annals of medicine
Published: October 13, 2025
A Case of Drug-Induced CA72-4 Pseudo-Elevation and Analysis of Its Causes.
Journal: Clinical laboratory
Published: October 13, 2025
Correction to "Gout Remission With Pegloticase-Induced Intensive Urate-Lowering Therapy: A Post Hoc Clinical Trial Analysis".
Journal: ACR open rheumatology
Published: October 06, 2025
Potential anti-gout properties and determined by UPLC-Q/TOF-MS of total saponins from Smilax nipponica Miq.
Journal: Natural product research
Published: October 06, 2025
Perspectives on the Management of Hyperuricemia and Gout in Older Adults.
Journal: The Senior care pharmacist
Published: October 03, 2025
Smoking Cessation and Gout Risk in Indigenous Populations: A Call for Causal Inference and Multiethnic Mendelian Randomization.
Journal: The Journal of rheumatology
Published: October 01, 2025
Do monosodium urate crystals reduce at different rates in joints and tendons during urate-lowering therapy? A dual energy CT study.
Journal: The Journal of rheumatology
Published: October 01, 2025
Effects of thyroid-stimulating hormone and sensitivity to thyroid hormones on the risk of hyperuricemia in euthyroid adults.
Journal: Archives of endocrinology and metabolism
Published: September 30, 2025
Essential oil from Goniothalamus elegans Ast leaves in Vietnam: chemical composition, nitric oxide inhibition, and xanthine oxidase inhibition activities.
Journal: Natural product research
Published: September 26, 2025
Reply to "Febuxostat use is associated with a significantly greater risk of mild to moderate perturbation of liver function compared to benzbromarone in patients with gout: comment on the article by Sun et al".
Journal: Arthritis care & research
Published: September 23, 2025
Last Updated: 10/31/2025